D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Henry Schein
HSIC
$8.39B
| $10.1M | 0.01% |
124,360
-161,216
| -56% | -$13.1M |
|
777
Usana Health Sciences
USNA
$562M
| $10.1M | 0.01% |
159,699
-11,961
| -7% | -$754K |
|
778
Brown & Brown
BRO
$30.9B
| $10.1M | 0.01% |
146,132
+18,805
| +15% | +$1.29M |
|
|
NFNT
779
DELISTED
Infinite Acquisition Corp.
NFNT
| $10M | 0.01% |
947,630
| – | – |
|
780
Quest Diagnostics
DGX
$20.4B
| $9.95M | 0.01% |
70,819
-38,641
| -35% | -$5.43M |
|
781
REV Group
REVG
$3.13B
| $9.93M | 0.01% |
748,824
+6,388
| +0.9% | +$84.7K |
|
|
AIV
782
Aimco
AIV
$1.08B
| $9.92M | 0.01% |
1,164,464
+456,226
| +64% | +$3.89M |
|
783
Erie Indemnity
ERIE
$17.6B
| $9.9M | 0.01% |
47,149
+42,693
| +958% | +$8.97M |
|
784
Payoneer
PAYO
$2.4B
| $9.9M | 0.01% |
2,058,299
+993,173
| +93% | +$4.78M |
|
785
Pembina Pipeline
PBA
$22.6B
| $9.87M | 0.01% |
314,019
-73,800
| -19% | -$2.32M |
|
786
Occidental Petroleum
OXY
$45.3B
| $9.83M | 0.01% |
167,247
-1,923,239
| -92% | -$113M |
|
787
Fastly
FSLY
$1.13B
| $9.82M | 0.01% |
622,439
-688,262
| -53% | -$10.9M |
|
788
Mettler-Toledo International
MTD
$26.4B
| $9.82M | 0.01% |
7,483
-4,770
| -39% | -$6.26M |
|
789
Exelixis
EXEL
$10.4B
| $9.79M | 0.01% |
512,349
-180,812
| -26% | -$3.46M |
|
790
Pitney Bowes
PBI
$1.97B
| $9.79M | 0.01% |
2,765,147
-249,238
| -8% | -$882K |
|
791
Factset
FDS
$13.9B
| $9.79M | 0.01% |
24,423
+20,694
| +555% | +$8.29M |
|
792
Ironwood Pharmaceuticals
IRWD
$197M
| $9.78M | 0.01% |
918,998
+118,275
| +15% | +$1.26M |
|
793
Darden Restaurants
DRI
$24.7B
| $9.76M | 0.01% |
58,430
-12,273
| -17% | -$2.05M |
|
794
SI-BONE Inc
SIBN
$694M
| $9.69M | 0.01% |
+359,211
| New | +$9.69M |
|
|
PDCO
795
DELISTED
Patterson Companies, Inc.
PDCO
| $9.69M | 0.01% |
291,273
+31,129
| +12% | +$1.04M |
|
796
US Bancorp
USB
$76.7B
| $9.66M | 0.01% |
292,481
-1,639,221
| -85% | -$54.2M |
|
797
CyberArk
CYBR
$23.8B
| $9.65M | 0.01% |
+61,747
| New | +$9.65M |
|
798
Voya Financial
VOYA
$7.35B
| $9.64M | 0.01% |
134,371
-505,630
| -79% | -$36.3M |
|
799
Genesco
GCO
$358M
| $9.63M | 0.01% |
384,736
+273,949
| +247% | +$6.86M |
|
800
Ingevity
NGVT
$2.14B
| $9.62M | 0.01% |
165,324
-205,321
| -55% | -$11.9M |
|